Name | (3α,16α)-Eburnamenine-14-carboxylic acid hydrochloride (1:1) |
---|---|
Synonyms |
(3α,16α)-Eburnamenine-14-carboxylic acid hydrochloride (1:1)
Eburnamenine-14-carboxylic acid, (3α,16α)-, hydrochloride (1:1) |
Description | Apovincaminic acid hydrochloride salt is an orally active and brain-penetrant main active metabolite of Vinpocetine (VP). Apovincaminic acid hydrochloride salt exerts a neuroprotective type of action[1][2]. |
---|---|
Related Catalog | |
In Vivo | Apovincaminic acid (10 mg/kg; i.p. twice daily for 4 days) effectively attenuates the behavioral deficits, and significantly decreases lesion size and the region of microglia activation[1]. Apovincaminic acid (10 mg/kg; p.o.) is absorbed 50% of the dose comparing with i.v. administration in rats[2]. Animal Model: Male Harlan‐Wistar rats (300-400 g) are injected NMDA[1] Dosage: 10 mg/kg Administration: I.p. twice daily for 4 days Result: Attenuated the attention deficit effectively. Prevented the learning and memory impairment in the spontaneous alternation and Morris water maze tests. significantly reduced lesion size microglia activation. |
References |
Molecular Formula | C20H23ClN2O2 |
---|---|
Molecular Weight | 358.862 |
Exact Mass | 358.144806 |